MorphoSys Raises '06 Revenue Guidance 4 Percent on Fatter Alliance Outlook | GenomeWeb
NEW YORK (GenomeWeb News) – MorphoSys raised its financial guidance for 2006, saying new collaborations would bump up revenues to €52 million ($66 million).
 
New collaborations and an extended collabration with Novartis would add €2 million to the expected 2006 revenue of €50 million.
 
The company also expects to lower expenses to €46 million from €49 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.